Nitrogen Mustards as Anticancer Chemotherapies: Historic Perspective, Current Developments and Future Trends

Area of Science:

• Oncology
• Pharmacology
• Medicinal Chemistry

Background:

• Nitrogen mustards are DNA alkylating agents that initiated cancer pharmacotherapy.
• Historically, their use was limited by dose-limiting toxic effects.
• Ongoing research aims to improve nitrogen mustards' selectivity and efficacy.

Purpose of the Study:

• To review the historical development of nitrogen mustards.
• To outline their mechanism of action and therapeutic improvements.
• To highlight advancements in nitrogen mustard prodrugs, particularly Cyclophosphamide.

Main Methods:

• Literature review of historical and recent developments in nitrogen mustard research.
• Analysis of structure-activity relationships for improved therapeutic profiles.
• Focus on prodrug strategies and their impact on efficacy and safety.

Main Results:

• Nitrogen mustards have evolved significantly since their inception.
• Rational structure modifications have led to safer and more effective agents.
• Prodrug approaches, exemplified by Cyclophosphamide, enhance therapeutic outcomes.

Conclusions:

• Nitrogen mustards remain a vital class of chemotherapeutic agents.
• Continued research focuses on optimizing selectivity and cytotoxic efficacy.
• Future trends involve further refinement of these agents for improved cancer treatment.